Vivos Inc (RDGL)

$0.07 +0.00 (3.56%)
Market Cap 30.97M
Revenue (ttm) 30,000.00
Net Income (ttm) -2.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,700.00%
Debt to Equity Ratio 0.00
Volume 585,200
Avg Vol 651,736
Day's Range N/A - N/A
Shares Out 455.49M
Stochastic %K 71%
Beta -0.50
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydro...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
anderson800
anderson800 Feb. 3 at 3:05 PM
$RDGL Does this mean no update on IDE submission until at least after 1st quarter completion? If update will include the enhanced protocol and that will not begin until later this quarter, it would seem update to IDE submission would have to be after that. "We continue to work toward anticipated DCGI regulatory clearance later this quarter to proceed with an expanded phase of therapy. This next stage would incorporate an enhanced protocol that includes elements suggested during prior FDA interactions, such as whole-body PET examinations, and would focus on treatment of cancerous lymph nodes throughout the body. We will provide an update to our IDE submission soon, incorporating relevant data from these ongoing demonstrations to further support our U.S. regulatory pathway."
2 · Reply
Den44
Den44 Feb. 3 at 2:27 PM
$RDGL BIG POSITIVE UPDATE ! https://www.globenewswire.com/news-release/2026/02/03/3231086/0/en/Vivos-Inc-Updates-Human-Therapy-Progress-in-India.html
0 · Reply
Fireballmillionaire
Fireballmillionaire Feb. 2 at 4:53 PM
$RDGL https://isopet.com/new-cancer-treatments-for-dogs-in-2026-what-pet-owners-should-know/
0 · Reply
LiCka_LoLLiStiCk
LiCka_LoLLiStiCk Feb. 1 at 3:05 AM
$RDGL We switched our main focus to India and internationally. Obviously it’s most likely because these areas have easier paths through trials and are cheaper to conduct. Tell me how we expect to fund a new manufacturing process and trials internationally with the cash we currently have? Tell me why the fda is “supposedly”needing more info for IDE approval after holding our hand through the entire process for the last 2, 3…4yrs? It’s not a product issue. IMO It’s a funding issue. It’ll be hard to find $9M+ sitting at $.06. FDA denials are stall tactics for what’s truly going on. They stated having a BP experimenting with Radiogel. This, combined with a shift in our focus leads me to believe a certain BP is interested and will either send a cash injection our way or a complete BO when they see proven results. Someone else with plenty of cash will lead this through FDA approval OR they’ll use the India trial results for FDA approval which is possible depending on certain requirements.
3 · Reply
GRIG330
GRIG330 Jan. 29 at 12:42 AM
$RDGL I’ve supported this stock for many many years but enough is enough. ALL shareholders need to reach out to the company to DEMAND answers on where they are at with the IDE. We have heard crickets for way too long. There is a lot of promise here still, but the management team needs to do a way better job of keeping investors updated
5 · Reply
Chapdaddy14
Chapdaddy14 Jan. 28 at 3:35 PM
$RMSL $RDGL 👀🔥🔥
1 · Reply
Doccjc62
Doccjc62 Jan. 28 at 2:29 PM
$RDGL “Building a defensible IP position remains a core strategy to drive shareholder value, support ongoing clinical progress, enable global commercial expansion, and position the company favorably for potential strategic partnerships or other opportunities." PrecisionGel imo has huge potentials on its own . Very excited to see where this goes .
0 · Reply
jhmlty
jhmlty Jan. 28 at 2:10 PM
$RDGL It's news. Not necessarily the news like a resubmission to the FDA, but the captain is still confident in his product. Lets see if he purchases more shares.
0 · Reply
Chapdaddy14
Chapdaddy14 Jan. 28 at 2:01 PM
$RDGL 👀
0 · Reply
Alacrity2
Alacrity2 Jan. 28 at 1:37 PM
$RDGL https://www.globenewswire.com/news-release/2026/01/28/3227615/0/en/Vivos-Inc-Strengthens-Patent-Protection-with-New-U-S-Patent-Issuance-and-PRECISIONGEL-Trademark-Approvals.html
1 · Reply
Latest News on RDGL
No data available.
anderson800
anderson800 Feb. 3 at 3:05 PM
$RDGL Does this mean no update on IDE submission until at least after 1st quarter completion? If update will include the enhanced protocol and that will not begin until later this quarter, it would seem update to IDE submission would have to be after that. "We continue to work toward anticipated DCGI regulatory clearance later this quarter to proceed with an expanded phase of therapy. This next stage would incorporate an enhanced protocol that includes elements suggested during prior FDA interactions, such as whole-body PET examinations, and would focus on treatment of cancerous lymph nodes throughout the body. We will provide an update to our IDE submission soon, incorporating relevant data from these ongoing demonstrations to further support our U.S. regulatory pathway."
2 · Reply
Den44
Den44 Feb. 3 at 2:27 PM
$RDGL BIG POSITIVE UPDATE ! https://www.globenewswire.com/news-release/2026/02/03/3231086/0/en/Vivos-Inc-Updates-Human-Therapy-Progress-in-India.html
0 · Reply
Fireballmillionaire
Fireballmillionaire Feb. 2 at 4:53 PM
$RDGL https://isopet.com/new-cancer-treatments-for-dogs-in-2026-what-pet-owners-should-know/
0 · Reply
LiCka_LoLLiStiCk
LiCka_LoLLiStiCk Feb. 1 at 3:05 AM
$RDGL We switched our main focus to India and internationally. Obviously it’s most likely because these areas have easier paths through trials and are cheaper to conduct. Tell me how we expect to fund a new manufacturing process and trials internationally with the cash we currently have? Tell me why the fda is “supposedly”needing more info for IDE approval after holding our hand through the entire process for the last 2, 3…4yrs? It’s not a product issue. IMO It’s a funding issue. It’ll be hard to find $9M+ sitting at $.06. FDA denials are stall tactics for what’s truly going on. They stated having a BP experimenting with Radiogel. This, combined with a shift in our focus leads me to believe a certain BP is interested and will either send a cash injection our way or a complete BO when they see proven results. Someone else with plenty of cash will lead this through FDA approval OR they’ll use the India trial results for FDA approval which is possible depending on certain requirements.
3 · Reply
GRIG330
GRIG330 Jan. 29 at 12:42 AM
$RDGL I’ve supported this stock for many many years but enough is enough. ALL shareholders need to reach out to the company to DEMAND answers on where they are at with the IDE. We have heard crickets for way too long. There is a lot of promise here still, but the management team needs to do a way better job of keeping investors updated
5 · Reply
Chapdaddy14
Chapdaddy14 Jan. 28 at 3:35 PM
$RMSL $RDGL 👀🔥🔥
1 · Reply
Doccjc62
Doccjc62 Jan. 28 at 2:29 PM
$RDGL “Building a defensible IP position remains a core strategy to drive shareholder value, support ongoing clinical progress, enable global commercial expansion, and position the company favorably for potential strategic partnerships or other opportunities." PrecisionGel imo has huge potentials on its own . Very excited to see where this goes .
0 · Reply
jhmlty
jhmlty Jan. 28 at 2:10 PM
$RDGL It's news. Not necessarily the news like a resubmission to the FDA, but the captain is still confident in his product. Lets see if he purchases more shares.
0 · Reply
Chapdaddy14
Chapdaddy14 Jan. 28 at 2:01 PM
$RDGL 👀
0 · Reply
Alacrity2
Alacrity2 Jan. 28 at 1:37 PM
$RDGL https://www.globenewswire.com/news-release/2026/01/28/3227615/0/en/Vivos-Inc-Strengthens-Patent-Protection-with-New-U-S-Patent-Issuance-and-PRECISIONGEL-Trademark-Approvals.html
1 · Reply
Techallure
Techallure Jan. 27 at 9:05 PM
$RDGL Ready for the return ? Be prepared
1 · Reply
Bigginfishnchips
Bigginfishnchips Jan. 27 at 1:35 PM
$RDGL I hope we get some news soon I need some excitement in my life.
4 · Reply
HATELIBERALS
HATELIBERALS Jan. 22 at 4:11 PM
$RDGL did the company make any announcements today?  I wonder what the quick drop in stock price was about.
2 · Reply
anderson800
anderson800 Jan. 22 at 12:24 PM
$RDGL been very quiet. No posts in the new year.
3 · Reply
TradingTomo
TradingTomo Jan. 20 at 9:39 PM
$RDGL haven’t opened this app in months
2 · Reply
Fireballmillionaire
Fireballmillionaire Jan. 19 at 2:42 PM
$RDGL hopefully a update comes out soon!! Isopet rollout still going on. India trials, prep for next fda resubmission.. Lack of volume, but value is here, this could jump big time with any news. I have added and am adding almost weekly.
1 · Reply
Bigginfishnchips
Bigginfishnchips Jan. 14 at 11:04 PM
$RDGL
0 · Reply
Den44
Den44 Jan. 14 at 3:31 PM
$RDGL LOAD THE BOAT
0 · Reply
SuperFunTime
SuperFunTime Jan. 10 at 12:14 PM
$RDGL what is IND timeline?
1 · Reply
Phil1981
Phil1981 Jan. 9 at 2:41 PM
$RDGL Seriously no one posted on this!?
3 · Reply
Richbagholderr
Richbagholderr Jan. 8 at 7:50 PM
$RDGL by the way, everyone thinks that the CEO is buying shares he’s actually be given them from the company. It’s happened every single year.
1 · Reply
Richbagholderr
Richbagholderr Jan. 8 at 7:48 PM
$RDGL only people posting positive things are shorting the hell out of this stock.
0 · Reply